0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Chronic Hepatitis B Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-17A14233
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Chronic Hepatitis B Virus Testing Market Research Report 2023
BUY CHAPTERS

Chronic Hepatitis B Virus Testing - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17A14233
Report
October 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Chronic Hepatitis B Virus Testing - Market Size

The global market for Chronic Hepatitis B Virus Testing was estimated to be worth US$ 859.7 million in 2023 and is forecast to a readjusted size of US$ 1371.5 million by 2030 with a CAGR of 6.9% during the forecast period 2024-2030

Chronic Hepatitis B Virus Testing - Market

Chronic Hepatitis B Virus Testing - Market

Chronic Hepatitis B Virus (HBV) testing refers to a series of laboratory tests that detect the presence of the virus in the blood over an extended period. Chronic hepatitis B is a condition in which the HBV infection lasts for more than six months.
North American market for Chronic Hepatitis B Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Chronic Hepatitis B Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Chronic Hepatitis B Virus Testing was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Chronic Hepatitis B Virus Testing include Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology and Bio-Rad Laboratories, Inc., etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Chronic Hepatitis B Virus Testing, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Chronic Hepatitis B Virus Testing by region & country, by Type, and by Application.
The Chronic Hepatitis B Virus Testing market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Hepatitis B Virus Testing.
Market Segmentation

Scope of Chronic Hepatitis B Virus Testing - Market Report

Report Metric Details
Report Name Chronic Hepatitis B Virus Testing - Market
Forecasted market size in 2030 US$ 1371.5 million
CAGR 6.9%
Forecasted years 2024 - 2030
Segment by Type:
  • Enzyme Immunoassay Kits
  • Hepatitis B Surface Antigen Test
  • Anti-Hepatitis B Surface Antibody Test
  • Anti-Hepatitis B Core Antibody Test
  • Point-of-Care Testing Kits
Segment by Application
  • Hospitals
  • Clinics
  • Diagnostic Centers
  • Home
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Chronic Hepatitis B Virus Testing manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Chronic Hepatitis B Virus Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Chronic Hepatitis B Virus Testing in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Chronic Hepatitis B Virus Testing - Market size in 2030?

Ans: The Chronic Hepatitis B Virus Testing - Market size in 2030 will be US$ 1371.5 million.

Who are the main players in the Chronic Hepatitis B Virus Testing - Market report?

Ans: The main players in the Chronic Hepatitis B Virus Testing - Market are Gilead Sciences, GlaxoSmithKline, Ionis Pharma, Janssen Sciences Ireland, Assembly Biosciences, Janssen and Arrowhead Pharmaceuticals, Roche, Vir Biotechnology, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., Abbott Laboratories, Meridian Bioscience

What are the Application segmentation covered in the Chronic Hepatitis B Virus Testing - Market report?

Ans: The Applications covered in the Chronic Hepatitis B Virus Testing - Market report are Hospitals, Clinics, Diagnostic Centers, Home

What are the Type segmentation covered in the Chronic Hepatitis B Virus Testing - Market report?

Ans: The Types covered in the Chronic Hepatitis B Virus Testing - Market report are Enzyme Immunoassay Kits, Hepatitis B Surface Antigen Test, Anti-Hepatitis B Surface Antibody Test, Anti-Hepatitis B Core Antibody Test, Point-of-Care Testing Kits

1 Market Overview
1.1 Chronic Hepatitis B Virus Testing Product Introduction
1.2 Global Chronic Hepatitis B Virus Testing Market Size Forecast
1.2.1 Global Chronic Hepatitis B Virus Testing Sales Value (2019-2030)
1.2.2 Global Chronic Hepatitis B Virus Testing Sales Volume (2019-2030)
1.2.3 Global Chronic Hepatitis B Virus Testing Sales Price (2019-2030)
1.3 Chronic Hepatitis B Virus Testing Market Trends & Drivers
1.3.1 Chronic Hepatitis B Virus Testing Industry Trends
1.3.2 Chronic Hepatitis B Virus Testing Market Drivers & Opportunity
1.3.3 Chronic Hepatitis B Virus Testing Market Challenges
1.3.4 Chronic Hepatitis B Virus Testing Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Chronic Hepatitis B Virus Testing Players Revenue Ranking (2023)
2.2 Global Chronic Hepatitis B Virus Testing Revenue by Company (2019-2024)
2.3 Global Chronic Hepatitis B Virus Testing Players Sales Volume Ranking (2023)
2.4 Global Chronic Hepatitis B Virus Testing Sales Volume by Company Players (2019-2024)
2.5 Global Chronic Hepatitis B Virus Testing Average Price by Company (2019-2024)
2.6 Key Manufacturers Chronic Hepatitis B Virus Testing Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Chronic Hepatitis B Virus Testing Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Chronic Hepatitis B Virus Testing
2.9 Chronic Hepatitis B Virus Testing Market Competitive Analysis
2.9.1 Chronic Hepatitis B Virus Testing Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Chronic Hepatitis B Virus Testing Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Virus Testing as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Enzyme Immunoassay Kits
3.1.2 Hepatitis B Surface Antigen Test
3.1.3 Anti-Hepatitis B Surface Antibody Test
3.1.4 Anti-Hepatitis B Core Antibody Test
3.1.5 Point-of-Care Testing Kits
3.2 Global Chronic Hepatitis B Virus Testing Sales Value by Type
3.2.1 Global Chronic Hepatitis B Virus Testing Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Chronic Hepatitis B Virus Testing Sales Value, by Type (2019-2030)
3.2.3 Global Chronic Hepatitis B Virus Testing Sales Value, by Type (%) (2019-2030)
3.3 Global Chronic Hepatitis B Virus Testing Sales Volume by Type
3.3.1 Global Chronic Hepatitis B Virus Testing Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Chronic Hepatitis B Virus Testing Sales Volume, by Type (2019-2030)
3.3.3 Global Chronic Hepatitis B Virus Testing Sales Volume, by Type (%) (2019-2030)
3.4 Global Chronic Hepatitis B Virus Testing Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals
4.1.2 Clinics
4.1.3 Diagnostic Centers
4.1.4 Home
4.2 Global Chronic Hepatitis B Virus Testing Sales Value by Application
4.2.1 Global Chronic Hepatitis B Virus Testing Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Chronic Hepatitis B Virus Testing Sales Value, by Application (2019-2030)
4.2.3 Global Chronic Hepatitis B Virus Testing Sales Value, by Application (%) (2019-2030)
4.3 Global Chronic Hepatitis B Virus Testing Sales Volume by Application
4.3.1 Global Chronic Hepatitis B Virus Testing Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Chronic Hepatitis B Virus Testing Sales Volume, by Application (2019-2030)
4.3.3 Global Chronic Hepatitis B Virus Testing Sales Volume, by Application (%) (2019-2030)
4.4 Global Chronic Hepatitis B Virus Testing Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Chronic Hepatitis B Virus Testing Sales Value by Region
5.1.1 Global Chronic Hepatitis B Virus Testing Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Chronic Hepatitis B Virus Testing Sales Value by Region (2019-2024)
5.1.3 Global Chronic Hepatitis B Virus Testing Sales Value by Region (2025-2030)
5.1.4 Global Chronic Hepatitis B Virus Testing Sales Value by Region (%), (2019-2030)
5.2 Global Chronic Hepatitis B Virus Testing Sales Volume by Region
5.2.1 Global Chronic Hepatitis B Virus Testing Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2019-2024)
5.2.3 Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2025-2030)
5.2.4 Global Chronic Hepatitis B Virus Testing Sales Volume by Region (%), (2019-2030)
5.3 Global Chronic Hepatitis B Virus Testing Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
5.4.2 North America Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
5.5.2 Europe Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
5.6.2 Asia Pacific Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
5.7.2 South America Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
5.8.2 Middle East & Africa Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value
6.2.1 Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.2.2 Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.3.2 United States Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.4.2 Europe Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.5.2 China Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.5.3 China Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.6.2 Japan Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.7.2 South Korea Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.8.2 Southeast Asia Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Chronic Hepatitis B Virus Testing Sales Value, 2019-2030
6.9.2 India Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
6.9.3 India Chronic Hepatitis B Virus Testing Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Gilead Sciences
7.1.1 Gilead Sciences Company Information
7.1.2 Gilead Sciences Introduction and Business Overview
7.1.3 Gilead Sciences Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Gilead Sciences Chronic Hepatitis B Virus Testing Product Offerings
7.1.5 Gilead Sciences Recent Development
7.2 GlaxoSmithKline
7.2.1 GlaxoSmithKline Company Information
7.2.2 GlaxoSmithKline Introduction and Business Overview
7.2.3 GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.2.4 GlaxoSmithKline Chronic Hepatitis B Virus Testing Product Offerings
7.2.5 GlaxoSmithKline Recent Development
7.3 Ionis Pharma
7.3.1 Ionis Pharma Company Information
7.3.2 Ionis Pharma Introduction and Business Overview
7.3.3 Ionis Pharma Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Ionis Pharma Chronic Hepatitis B Virus Testing Product Offerings
7.3.5 Ionis Pharma Recent Development
7.4 Janssen Sciences Ireland
7.4.1 Janssen Sciences Ireland Company Information
7.4.2 Janssen Sciences Ireland Introduction and Business Overview
7.4.3 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product Offerings
7.4.5 Janssen Sciences Ireland Recent Development
7.5 Assembly Biosciences
7.5.1 Assembly Biosciences Company Information
7.5.2 Assembly Biosciences Introduction and Business Overview
7.5.3 Assembly Biosciences Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Assembly Biosciences Chronic Hepatitis B Virus Testing Product Offerings
7.5.5 Assembly Biosciences Recent Development
7.6 Janssen and Arrowhead Pharmaceuticals
7.6.1 Janssen and Arrowhead Pharmaceuticals Company Information
7.6.2 Janssen and Arrowhead Pharmaceuticals Introduction and Business Overview
7.6.3 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product Offerings
7.6.5 Janssen and Arrowhead Pharmaceuticals Recent Development
7.7 Roche
7.7.1 Roche Company Information
7.7.2 Roche Introduction and Business Overview
7.7.3 Roche Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Roche Chronic Hepatitis B Virus Testing Product Offerings
7.7.5 Roche Recent Development
7.8 Vir Biotechnology
7.8.1 Vir Biotechnology Company Information
7.8.2 Vir Biotechnology Introduction and Business Overview
7.8.3 Vir Biotechnology Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Vir Biotechnology Chronic Hepatitis B Virus Testing Product Offerings
7.8.5 Vir Biotechnology Recent Development
7.9 Bio-Rad Laboratories, Inc.
7.9.1 Bio-Rad Laboratories, Inc. Company Information
7.9.2 Bio-Rad Laboratories, Inc. Introduction and Business Overview
7.9.3 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product Offerings
7.9.5 Bio-Rad Laboratories, Inc. Recent Development
7.10 DiaSorin S.p.A.
7.10.1 DiaSorin S.p.A. Company Information
7.10.2 DiaSorin S.p.A. Introduction and Business Overview
7.10.3 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.10.4 DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product Offerings
7.10.5 DiaSorin S.p.A. Recent Development
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Information
7.11.2 Abbott Laboratories Introduction and Business Overview
7.11.3 Abbott Laboratories Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Abbott Laboratories Chronic Hepatitis B Virus Testing Product Offerings
7.11.5 Abbott Laboratories Recent Development
7.12 Meridian Bioscience
7.12.1 Meridian Bioscience Company Information
7.12.2 Meridian Bioscience Introduction and Business Overview
7.12.3 Meridian Bioscience Chronic Hepatitis B Virus Testing Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Meridian Bioscience Chronic Hepatitis B Virus Testing Product Offerings
7.12.5 Meridian Bioscience Recent Development
8 Industry Chain Analysis
8.1 Chronic Hepatitis B Virus Testing Industrial Chain
8.2 Chronic Hepatitis B Virus Testing Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Chronic Hepatitis B Virus Testing Sales Model
8.5.2 Sales Channel
8.5.3 Chronic Hepatitis B Virus Testing Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
    Table 1. Chronic Hepatitis B Virus Testing Market Trends
    Table 2. Chronic Hepatitis B Virus Testing Market Drivers & Opportunity
    Table 3. Chronic Hepatitis B Virus Testing Market Challenges
    Table 4. Chronic Hepatitis B Virus Testing Market Restraints
    Table 5. Global Chronic Hepatitis B Virus Testing Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Chronic Hepatitis B Virus Testing Revenue Market Share by Company (2019-2024)
    Table 7. Global Chronic Hepatitis B Virus Testing Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Chronic Hepatitis B Virus Testing Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Chronic Hepatitis B Virus Testing Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Chronic Hepatitis B Virus Testing Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Chronic Hepatitis B Virus Testing Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Chronic Hepatitis B Virus Testing
    Table 13. Global Chronic Hepatitis B Virus Testing Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Hepatitis B Virus Testing as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Chronic Hepatitis B Virus Testing Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Chronic Hepatitis B Virus Testing Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Chronic Hepatitis B Virus Testing Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Chronic Hepatitis B Virus Testing Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Chronic Hepatitis B Virus Testing Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Chronic Hepatitis B Virus Testing Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Chronic Hepatitis B Virus Testing Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Chronic Hepatitis B Virus Testing Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Chronic Hepatitis B Virus Testing Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Chronic Hepatitis B Virus Testing Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Chronic Hepatitis B Virus Testing Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Chronic Hepatitis B Virus Testing Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Chronic Hepatitis B Virus Testing Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Chronic Hepatitis B Virus Testing Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Chronic Hepatitis B Virus Testing Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Chronic Hepatitis B Virus Testing Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Chronic Hepatitis B Virus Testing Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Chronic Hepatitis B Virus Testing Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Chronic Hepatitis B Virus Testing Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Chronic Hepatitis B Virus Testing Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Chronic Hepatitis B Virus Testing Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Chronic Hepatitis B Virus Testing Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Chronic Hepatitis B Virus Testing Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Chronic Hepatitis B Virus Testing Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Chronic Hepatitis B Virus Testing Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Chronic Hepatitis B Virus Testing Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Chronic Hepatitis B Virus Testing Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Chronic Hepatitis B Virus Testing Sales Value by Region (2019-2024) & (%)
    Table 44. Global Chronic Hepatitis B Virus Testing Sales Value by Region (2025-2030) & (%)
    Table 45. Global Chronic Hepatitis B Virus Testing Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Chronic Hepatitis B Virus Testing Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Chronic Hepatitis B Virus Testing Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Chronic Hepatitis B Virus Testing Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Volume, (2025-2030) & (K Units)
    Table 57. Gilead Sciences Company Information
    Table 58. Gilead Sciences Introduction and Business Overview
    Table 59. Gilead Sciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Gilead Sciences Chronic Hepatitis B Virus Testing Product Offerings
    Table 61. Gilead Sciences Recent Development
    Table 62. GlaxoSmithKline Company Information
    Table 63. GlaxoSmithKline Introduction and Business Overview
    Table 64. GlaxoSmithKline Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. GlaxoSmithKline Chronic Hepatitis B Virus Testing Product Offerings
    Table 66. GlaxoSmithKline Recent Development
    Table 67. Ionis Pharma Company Information
    Table 68. Ionis Pharma Introduction and Business Overview
    Table 69. Ionis Pharma Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Ionis Pharma Chronic Hepatitis B Virus Testing Product Offerings
    Table 71. Ionis Pharma Recent Development
    Table 72. Janssen Sciences Ireland Company Information
    Table 73. Janssen Sciences Ireland Introduction and Business Overview
    Table 74. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Janssen Sciences Ireland Chronic Hepatitis B Virus Testing Product Offerings
    Table 76. Janssen Sciences Ireland Recent Development
    Table 77. Assembly Biosciences Company Information
    Table 78. Assembly Biosciences Introduction and Business Overview
    Table 79. Assembly Biosciences Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Assembly Biosciences Chronic Hepatitis B Virus Testing Product Offerings
    Table 81. Assembly Biosciences Recent Development
    Table 82. Janssen and Arrowhead Pharmaceuticals Company Information
    Table 83. Janssen and Arrowhead Pharmaceuticals Introduction and Business Overview
    Table 84. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Janssen and Arrowhead Pharmaceuticals Chronic Hepatitis B Virus Testing Product Offerings
    Table 86. Janssen and Arrowhead Pharmaceuticals Recent Development
    Table 87. Roche Company Information
    Table 88. Roche Introduction and Business Overview
    Table 89. Roche Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Roche Chronic Hepatitis B Virus Testing Product Offerings
    Table 91. Roche Recent Development
    Table 92. Vir Biotechnology Company Information
    Table 93. Vir Biotechnology Introduction and Business Overview
    Table 94. Vir Biotechnology Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Vir Biotechnology Chronic Hepatitis B Virus Testing Product Offerings
    Table 96. Vir Biotechnology Recent Development
    Table 97. Bio-Rad Laboratories, Inc. Company Information
    Table 98. Bio-Rad Laboratories, Inc. Introduction and Business Overview
    Table 99. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Bio-Rad Laboratories, Inc. Chronic Hepatitis B Virus Testing Product Offerings
    Table 101. Bio-Rad Laboratories, Inc. Recent Development
    Table 102. DiaSorin S.p.A. Company Information
    Table 103. DiaSorin S.p.A. Introduction and Business Overview
    Table 104. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. DiaSorin S.p.A. Chronic Hepatitis B Virus Testing Product Offerings
    Table 106. DiaSorin S.p.A. Recent Development
    Table 107. Abbott Laboratories Company Information
    Table 108. Abbott Laboratories Introduction and Business Overview
    Table 109. Abbott Laboratories Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Abbott Laboratories Chronic Hepatitis B Virus Testing Product Offerings
    Table 111. Abbott Laboratories Recent Development
    Table 112. Meridian Bioscience Company Information
    Table 113. Meridian Bioscience Introduction and Business Overview
    Table 114. Meridian Bioscience Chronic Hepatitis B Virus Testing Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Meridian Bioscience Chronic Hepatitis B Virus Testing Product Offerings
    Table 116. Meridian Bioscience Recent Development
    Table 117. Key Raw Materials Lists
    Table 118. Raw Materials Key Suppliers Lists
    Table 119. Chronic Hepatitis B Virus Testing Downstream Customers
    Table 120. Chronic Hepatitis B Virus Testing Distributors List
    Table 121. Research Programs/Design for This Report
    Table 122. Key Data Information from Secondary Sources
    Table 123. Key Data Information from Primary Sources
List of Figures
    Figure 1. Chronic Hepatitis B Virus Testing Product Picture
    Figure 2. Global Chronic Hepatitis B Virus Testing Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Chronic Hepatitis B Virus Testing Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Chronic Hepatitis B Virus Testing Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Chronic Hepatitis B Virus Testing Report Years Considered
    Figure 7. Global Chronic Hepatitis B Virus Testing Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Chronic Hepatitis B Virus Testing Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Chronic Hepatitis B Virus Testing Revenue in 2023
    Figure 10. Chronic Hepatitis B Virus Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Enzyme Immunoassay Kits Picture
    Figure 12. Hepatitis B Surface Antigen Test Picture
    Figure 13. Anti-Hepatitis B Surface Antibody Test Picture
    Figure 14. Anti-Hepatitis B Core Antibody Test Picture
    Figure 15. Point-of-Care Testing Kits Picture
    Figure 16. Global Chronic Hepatitis B Virus Testing Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Chronic Hepatitis B Virus Testing Sales Value Market Share by Type, 2023 & 2030
    Figure 18. Global Chronic Hepatitis B Virus Testing Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 19. Global Chronic Hepatitis B Virus Testing Sales Volume Market Share by Type, 2023 & 2030
    Figure 20. Global Chronic Hepatitis B Virus Testing Price by Type (2019-2030) & (US$/Unit)
    Figure 21. Product Picture of Hospitals
    Figure 22. Product Picture of Clinics
    Figure 23. Product Picture of Diagnostic Centers
    Figure 24. Product Picture of Home
    Figure 25. Global Chronic Hepatitis B Virus Testing Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Chronic Hepatitis B Virus Testing Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Chronic Hepatitis B Virus Testing Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 28. Global Chronic Hepatitis B Virus Testing Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Chronic Hepatitis B Virus Testing Price by Application (2019-2030) & (US$/Unit)
    Figure 30. North America Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Chronic Hepatitis B Virus Testing Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Chronic Hepatitis B Virus Testing Sales Volume (%), (2019-2030)
    Figure 42. United States Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Chronic Hepatitis B Virus Testing Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Chronic Hepatitis B Virus Testing Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Chronic Hepatitis B Virus Testing Sales Value by Application (%), 2023 VS 2030
    Figure 63. Chronic Hepatitis B Virus Testing Industrial Chain
    Figure 64. Chronic Hepatitis B Virus Testing Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Add to Cart

Add to Cart

Meningococcal Disease Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-37Q13661
Wed Nov 06 00:00:00 UTC 2024

Add to Cart